ALDX Investor Alert: Aldeyra Therapeutics Securities Fraud Lawsuit – Investors With Losses May Seek to Lead the Class Action After Executives Allegedly Omitted Inconsistent Trial Data: Levi & Korsinsky

TIPRANKS04-17 21:45

NEW YORK, April 17, 2026 — Institutional investors holding positions in Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) during the period between Novembe...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2628820237?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-17 21:45","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2628820237","market":"nz","top_or_hot":-1,"title":"ALDX Investor Alert: Aldeyra Therapeutics Securities Fraud Lawsuit – Investors With Losses May Seek to Lead the Class Action After Executives Allegedly Omitted Inconsistent Trial Data: Levi & Korsinsky","media":"TIPRANKS","content":"<div>\n<p>NEW YORK, April 17, 2026 — Institutional investors holding positions in Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) during the period between Novembe...</p>\n\n<a href=\"https://www.tipranks.com/news/class-action/aldx-investor-alert-aldeyra-therapeutics-securities-fraud-lawsuit-investors-with-losses-may-seek-to-lead-the-class-action-after-executives-allegedly-omitted-inconsistent-trial-data-levi-korsinsk?utm_source=itigerup.com&utm_medium=referral\">Source Link</a>\n\n</div>\n","source":"tipranks_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ALDX Investor Alert: Aldeyra Therapeutics Securities Fraud Lawsuit – Investors With Losses May Seek to Lead the Class Action After Executives Allegedly Omitted Inconsistent Trial Data: Levi & Korsinsky</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nALDX Investor Alert: Aldeyra Therapeutics Securities Fraud Lawsuit – Investors With Losses May Seek to Lead the Class Action After Executives Allegedly Omitted Inconsistent Trial Data: Levi & Korsinsky\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-04-17 21:45 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.tipranks.com/news/class-action/aldx-investor-alert-aldeyra-therapeutics-securities-fraud-lawsuit-investors-with-losses-may-seek-to-lead-the-class-action-after-executives-allegedly-omitted-inconsistent-trial-data-levi-korsinsk?utm_source=itigerup.com&utm_medium=referral><strong>TIPRANKS</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>NEW YORK, April 17, 2026 — Institutional investors holding positions in Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) during the period between Novembe...</p>\n\n<a href=\"https://www.tipranks.com/news/class-action/aldx-investor-alert-aldeyra-therapeutics-securities-fraud-lawsuit-investors-with-losses-may-seek-to-lead-the-class-action-after-executives-allegedly-omitted-inconsistent-trial-data-levi-korsinsk?utm_source=itigerup.com&utm_medium=referral\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"QQQ","symbol_name":"纳指100ETF","start_time":0,"source_url":"https://www.tipranks.com/news/class-action/aldx-investor-alert-aldeyra-therapeutics-securities-fraud-lawsuit-investors-with-losses-may-seek-to-lead-the-class-action-after-executives-allegedly-omitted-inconsistent-trial-data-levi-korsinsk?utm_source=itigerup.com&utm_medium=referral","article_id":"2628820237","we_media_id":null,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/class-action/aldx-investor-alert-aldeyra-therapeutics-securities-fraud-lawsuit-investors-with-losses-may-seek-to-lead-the-class-action-after-executives-allegedly-omitted-inconsistent-trial-data-levi-korsinsk?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2628820237","pubTimestamp":1776433511,"columns":[],"sourceInfo":{"source_id":"tipranks_highlight","name":"Tipranks"},"weMediaInfo":null,"summary":"NEW YORK, April 17, 2026 — Institutional investors holding positions in Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) during the period between Novembe...","collect":0,"end_time":0,"defaultTopTitle":"tipranks.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"QQQ":"纳指100ETF","ONEQ":"Fidelity NASDAQ Composite Index ETF","QID":"两倍做空纳斯达克指数ETF-ProShares","QQQE":"Direxion NASDAQ-100 Equal Weighted Index Shares","SQQQ":"纳指三倍做空ETF","BK4211":"区域性银行","FTEC":"Fidelity MSCI Information Techno","QQQA":"ProShares Nasdaq-100 Dorsey Wright Momentum ETF","PSQ":"做空纳斯达克100指数ETF-ProShares","DBB":"基础金属ETF-PowerShares","QDTE":"Roundhill N-100 0DTE Covered Call Strategy ETF","BK4139":"生物科技","ALDX":"Aldeyra Therapeutics Inc","JEPQ":"JPMorgan Nasdaq Equity Premium Income ETF","QQQY":"Defiance Nasdaq 100 Enhanced Options & 0DTE Income ETF","NVIW.SI":"NVDA 3xLongSG261006","IYW":"美国科技ETF-iShares","QQQM":"NASDAQ100指数ETF-Invesco","GPIQ":"GOLDMAN SACHS NASDAQ 100 CORE PREMIUM INCOME ETF","TQQQ":"纳指三倍做多ETF","QQQJ":"Invesco NASDAQ Next Gen 100 ETF","TQQY":"GraniteShares YieldBOOST QQQ ETF",".IXIC":"NASDAQ Composite","ISBC":"投资者银行","QYLG":"Nasdaq 100 Covered Call & Growth ETF","QLD":"2倍做多纳斯达克100指数ETF-ProShares","NDX":"纳斯达克100指数"},"translate_title":"ALDX投资者提醒：Aldeyra Therapeutics证券欺诈诉讼-在高管涉嫌遗漏不一致的试验数据后，遭受损失的投资者可能会寻求领导集体诉讼：Levi&Korsinsky","themeId":null,"isJumpTheme":false,"ttsUrl":"https://static.tigerbbs.com/9586054e90cdf66ec19f387ce55a889e","symbols_score_info":{"QLD":0.6,"NDX":0.6,"QQQM":0.6,"GPIQ":0.6,"QDTE":0.6,"DBB":1.5,"TQQY":0.6,"NQmain":0.6,"MNQmain":0.6,"QID":0.6,"ISBC":1.5,"QQQE":0.6,"QQQA":0.6,"NVIW.SI":0.6,"QQQJ":0.6,"QYLG":0.6,".IXIC":0.9,"QQQ":0.6,"ALDX":1.5,"IYW":0.6,"QQQY":0.6,"JEPQ":0.6,"FTEC":0.6,"SQQQ":0.6,"PSQ":0.6,"TQQQ":0.6,"ONEQ":0.6},"content_text":"NEW YORK, April 17, 2026 — Institutional investors holding positions in Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) during the period between Novembe...","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"executive","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2628820237","isCrawlerRequest":true}